Topical radiological or surgical ablation may be considered for the management of patients with oligometastatic disease, and the latter pattern of tumor appearance is characteristic for BRCA1/2-driven tumors exposed to platinum-based therapy [83, 84]. The gene discussed is BRCA1; the disease is neoplasm.